The use of angiotensin I derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders

Details for Australian Patent Application No. 2002311741 (hide)

International Classifications

Event Publications

2 January 2003 Complete Application Filed

Priority application(s): 09/895,273 29.06.01 US

15 May 2003 Application Open to Public Inspection

Published as AU-B-2002311741

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2E(2). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

15 November 2007 Section 223 Application Allowed

National University of Singapore The time in which to pay the exam response fee has been extended to 16 Oct 2007. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 38 MLC Centre Martin Place Sydney NSW 2000

22 November 2007 Application Accepted

Published as AU-B-2002311741

20 March 2008 Standard Patent Sealed

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.